Vascular Function, Insulin Sensitivity, and Vitamin D

Completed

• Conditions: Flow-mediated Dilation; Arterial Stiffness; Insulin Sensitivity

• Registration Number: NCT01041547
• Lead Sponsor: University of Alabama at Birmingham

Brief Summary

The overall objectives of this study are to examine the relationships between circulating vitamin D, insulin sensitivity, and multiple indices of vascular function and to examine whether vitamin D deficiency in African Americans (AA) and White Hispanics (WH) is responsible for ethnic differences in insulin sensitivity and hypertension in AA, WH and European Americans (EA), as well as mechanisms underlying the association between insulin resistance and blood pressure. We hypothesize that 1) serum 25(OH)D is associated with insulin sensitivity and vascular functioning, independent of adiposity, 2) lower insulin sensitivity and vascular functioning in AA and WH relative to EA is due to lower circulating 25(OH)D in AA, and 3) the relationship between insulin resistance and vascular dysfunction is mediated by 25(OH)D.

Acronyms: African American (AA), European American (EA), White Hispanics (WH), Serum 25-hydroxy vitamin D (25()H)D, Body mass index (BMI), Alabama (AL).

Detailed Description

Not available

Study Timeline

• Study Start: 2009-12
• Study First Submitted: 2009-12-28
• Study First Submitted QC: 2009-12-30
• Study First Posted: 2009-12-31
• Primary Completion: 2012-12
• Study Completion: 2013-12
• Status Verified: 2014-01
• Last Update Submitted: 2014-01-13
• Last Update Posted: 2014-01-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 63

Inclusion Criteria

• African American (AA), White Hispanic (WH), and European American (EA) race
• Ages 19-60 years
• Negative urine pregnancy test
• No evidence of diabetes
• Not on medications that can affect vascular functioning or insulin sensitivity

Exclusion Criteria

• BMI > 32 kg/m2
• Diabetes or any chronic diseases
• Use of medication(s) known to influence body composition, vascular function, or glucose metabolism
• Regular smoking
• Regular use of illegal drugs and pregnancy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin sensitivity	Cross sectional study: at first study visit

Secondary Outcome Measures

Name	Time	Method
Vascular function	Cross sectional study: at second study visit, within 2 weeks of first study visit

Trial Locations

Locations (1)

University of Alabama; 🇺🇸 Birmingham, Alabama, United States